PW Medtech Group Limited (1358.HK) — Stock Score Summary

PW Medtech Group Limited (1358.HK) has a MoatMap StockRank of 73/100 based on Quality (61/100), Value (63/100), and Momentum (33/100) factor scores. The current signal is BUY. PW Medtech is a Chinese medical device company focusing on blood purification and infusion sets. It lacks the global scale, proprietary technology, and pricing power to benefit from the high-value CDMO pricing cycle.

PW Medtech Group Limited is a medical device company engaged in the research, development, manufacturing, and distribution of a range of medical instruments and supplies, particularly in the cardiovascular and orthopedic fields. The company focuses on innovative solutions and holds proprietary technologies for its key products, aiming to address unmet medical needs. Its R&D capabilities and specialized product portfolio position it as a significant player in the growing Chinese medical device market.

Key Financial Metrics

Price$0.15
Market Cap$214M
P/E (TTM)16.71
Price/Book0.38
Return on Equity2.8%
Return on Invested Capital3.3%
Debt/Equity0.45
Gross Margin49.5%
Operating Margin10.3%
Revenue Growth-5.0%
Dividend Yield5.5%
Free Cash Flow$276K

PW Medtech Group Limited operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is PW Medtech Group Limited’s (1358.HK) StockRank?
MoatMap’s StockRank for PW Medtech Group Limited (1358.HK) is 73/100, with a Buy signal. It is a composite of Quality (61), Value (63), and Momentum (33) factor ranks across MoatMap’s 19,000+ stock universe.
Does PW Medtech Group Limited have an economic moat?
PW Medtech Group Limited (1358.HK) has a Quality factor score of 61/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is PW Medtech Group Limited a buy, hold, or sell?
MoatMap’s current signal for PW Medtech Group Limited (1358.HK) is Buy, based on a StockRank of 73/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is PW Medtech Group Limited in?
PW Medtech Group Limited (1358.HK) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (China).